From the horse's mouth ( and not an email to friends) announced to the market less than a month ago in their April Investor Presentation..........
""Phase IIb trial (63 patients) for ovarian cancer patients after successful 1st or 2nd line therapy has completed recruiting patients in U.S. & Australia to:
–Assure comparability of multiple manufacturing centers
–Confirm safety & tolerability established in earlier trials
–Compare CVac to standard of care (progression-free survival)
–Confirm host immunologic response to CVac therapy
–Recruitment completed in September 2011
–Interim PFS Data in 2012
–Final PFS Data anticipated in 2013""
From the horse's mouth ( and not an email to friends) announced...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 32.5¢ | $659.6K | 1.969M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 399004 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 4457 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |